Worth Venture Partners, LLC Vanda Pharmaceuticals Inc. Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$13.42 - $20.28 $1.2 Million - $1.81 Million
-89,124 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$9.77 - $13.81 $61,892 - $87,486
6,335 Added 7.65%
89,124 $1.17 Million
Q3 2020

Nov 16, 2020
BUY
$9.32 - $12.02 $771,593 - $995,123
82,789 New
82,789 $799,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.3M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $282M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email